Biopharmaceutical company utilizing TransCon technology to create long-acting therapies for rare diseases.
Publicité
Publicité
RASND
Ascendis Pharma A/S rStock
244.36
19 sept., 03:47 UTC
About
Informations et liens
Site Internet
Contrats
- arbitrum-one:0xa1b…2b3ac
- morph-l2:0xa47…ea778
En savoir plus
Données provenant de